327 filings
Page 2 of 17
8-K
z74mfj4xh2d2eo
4 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:52pm
8-K
ly08dnzqx48yi
30 Nov 22
Alaunos Therapeutics Announces Proposed Public Offering of Common Stock
5:10pm
8-K
joomx064 9ucw
14 Nov 22
Alaunos Therapeutics Reports Third Quarter 2022 Financial Results
7:06am
8-K
kwa8gc
7 Nov 22
Alaunos Therapeutics to Present Data Highlighting its hunTRâ„¢ TCR Discovery
8:10am
8-K
ayvorr91pu3a1usmgh8k
30 Sep 22
Other Events
8:00am
8-K
mowg43 ulj
21 Sep 22
Alaunos Therapeutics Highlights Data from TCR-T Library Phase 1/2 Trial at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference
8:41am
8-K
eddx 6s2xsu2z2hl
6 Sep 22
Alaunos Therapeutics Announces Early Clinical Data Showing Objective Clinical Response Using its TCR-T Cell Therapy
8:21am
8-K
48f9a c1pp6
24 Aug 22
Alaunos Therapeutics to Present at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference
4:45pm
8-K
i5ramn0uf 9feklzwyqf
15 Aug 22
Alaunos Therapeutics Reports Second Quarter 2022 Financial Results
7:07am
8-K
a8uj6a7mm3at29wn91r
4 Aug 22
Alaunos Therapeutics Appoints Abhishek Srivastava, Ph.D. as Vice President, Technical Operations
5:13pm
8-K
xxmeu3
13 Jul 22
Other Events
8:00am
8-K
6isaf00a6lq5hi111tl
27 Jun 22
Entry into a Material Definitive Agreement
8:07am
8-K
ay9ep6ey
17 Jun 22
Material Modifications to Rights of Security Holders
4:31pm
8-K
j3ewdy7sb
24 May 22
Regulation FD Disclosure
8:30am
8-K
3offqqt
16 May 22
Alaunos Therapeutics Reports First Quarter 2022 Financial Results
7:30am
8-K
6khzdctg
2 May 22
Alaunos Therapeutics to Present at American Society of Gene and Cell Therapy
4:31pm
8-K
wney40rf6y
2 May 22
Alaunos Therapeutics Doses First Patient in TCR-T Library Phase 1/2 trial for the Treatment of Patients with Solid Tumors
8:31am
8-K
e5q7ghft
30 Mar 22
Alaunos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
7:41am
8-K
rxlaoknv069
18 Mar 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
8-K
wf5 p3mmqfb5vybmv
17 Mar 22
Entry into a Material Definitive Agreement
8:30am